Published • loading... • Updated
Epigenetics Market to Reach $3.92 Billion by 2031, Fueled by Advances in Precision Medicine and NGS-Based Profiling
- The global Epigenetics Market is projected to grow from USD 2.22 billion in 2026 to USD 3.92 billion by 2031, with a CAGR of 12.0% during the forecast period.
- Growth is driven by increasing use of epigenomic profiling technologies in oncology, precision medicine, drug discovery, and biomarker research.
- Pharmaceutical and biotechnology companies utilize techniques such as DNA methylation analysis, ChIP-seq, ATAC-seq, RNA sequencing, and NGS-based epigenetic profiling to study gene regulation and disease progression.
- In 2025, the kits & reagents segment and next-generation sequencing technology held the largest market shares, with North America being the largest regional market.
Insights by Ground AI
34 Articles
34 Articles
4th of July SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources34
Leaning Left8Leaning Right4Center12Last UpdatedBias Distribution50% Center
Bias Distribution
- 50% of the sources are Center
50% Center
L 33%
C 50%
R 17%
Factuality
To view factuality data please Upgrade to Premium
